Back
Aclaris Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
69
ACRS
Aclaris Therapeutics, Inc.
Last Price:
$3.04
Seasonality Move:
42.41%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and ACRS is experiencing slight buying pressure.
Aclaris Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.12 | Sell |
| 20-day SMA: | 3.03 | Buy |
| 50-day SMA: | 2.6 | Buy |
| 200-day SMA: | 1.83 | Buy |
| 8-day EMA: | 3.1 | Sell |
| 20-day EMA: | 2.99 | Buy |
| 50-day EMA: | 2.67 | Buy |
| 200-day EMA: | 2.14 | Buy |
Aclaris Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 54.59 | Buy |
| Chaikin Money Flow: | 195718 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.65 - 3.21) | Buy |
| Bollinger Bands (100): | (1.75 - 2.71) | Buy |
Aclaris Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aclaris Therapeutics, Inc. Stock
Is Aclaris Therapeutics, Inc. Stock a Buy?
-
Aclaris Therapeutics, Inc. share price is 3.04 while ACRS 8-day simple moving average is 3.12, which is a Sell signal.
-
The stock price of ACRS is 3.04 while Aclaris Therapeutics, Inc. 20-day SMA is 3.03, which makes it a Buy.
-
Aclaris Therapeutics, Inc. 50-day simple moving average is 2.60 while ACRS share price is 3.04, making it a Buy technically.
-
ACRS stock price is 3.04 and Aclaris Therapeutics, Inc. 200-day simple moving average is 1.83, creating a Buy signal.
ACRS Technical Analysis vs Fundamental Analysis
Buy
69
Aclaris Therapeutics, Inc. (ACRS)
is a Buy
Is Aclaris Therapeutics, Inc. a Buy or a Sell?
-
Aclaris Therapeutics, Inc. stock is rated a BuyThe current Aclaris Therapeutics, Inc. [ACRS] share price is $3.04. The Score for ACRS is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
Aclaris Therapeutics, Inc. Stock Info
Market Cap:
329.4M
Price in USD:
3.04
Share Volume:
440.4K
Aclaris Therapeutics, Inc. 52-Week Range
52-Week High:
3.48
52-Week Low:
1.05
Buy
69
Aclaris Therapeutics, Inc. (ACRS)
is a Buy
Aclaris Therapeutics, Inc. Share Price Forecast
-
What is the Aclaris Therapeutics, Inc. stock price today?The Aclaris Therapeutics, Inc. stock price is 3.04 USD today.
-
Will ACRS stock go up or go down?Aclaris Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Aclaris Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aclaris Therapeutics, Inc. is not overvalued.
Is Aclaris Therapeutics, Inc. Stock a Buy?
-
Aclaris Therapeutics, Inc. share price is 3.04 while ACRS 8-day exponential moving average is 3.10, which is a Sell signal.
-
The stock price of ACRS is 3.04 while Aclaris Therapeutics, Inc. 20-day EMA is 2.99, which makes it a Buy.
-
Aclaris Therapeutics, Inc. 50-day exponential moving average is 2.67 while ACRS share price is 3.04, making it a Buy technically.
-
ACRS stock price is 3.04 and Aclaris Therapeutics, Inc. 200-day simple moving average is 2.14, creating a Buy signal.
Fundamental Analysis of Aclaris Therapeutics, Inc.
Is Aclaris Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.07 per share.
Technical Analysis of Aclaris Therapeutics, Inc.
Should I short Aclaris Therapeutics, Inc. stock?
-
ACRS Moving Average Covergence Divergence (MACD) indicator is 0.16, suggesting Aclaris Therapeutics, Inc. is a Buy
-
Aclaris Therapeutics, Inc. Relative Strength Index (RSI) is 54.59, which suggest Aclaris Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Aclaris Therapeutics, Inc. is (2.65 - 3.21), which suggest Aclaris Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Aclaris Therapeutics, Inc. is (1.75 - 2.71), which suggest Aclaris Therapeutics, Inc. is a Buy
* Aclaris Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.